Patent details
EP2125019 Title: IMPROVED MEDICINAL COMPOSITIONS COMPRISING BUPRENORPHINE AND NALTREXONE
Basic Information
- Publication number:
- EP2125019
- PCT Application Number:
- PCT/GB/2008/000521
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087094124
- PCT Publication Number:
- WO/2008/104735
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMPROVED MEDICINAL COMPOSITIONS COMPRISING BUPRENORPHINE AND NALTREXONE
- French Title of Invention:
- COMPOSITIONS MÉDICINALES AMÉLIORÉES COMPRENANT DE LA BUPRÉNORPHINE ET DE LA NALTREXONE
- German Title of Invention:
- BUPRENORPHIN UND NALTREXON ENTHALTENDE VERBESSERTE MEDIZINISCHE ZUSAMMENSETZUNG
- SPC Number:
Dates
- Filing date:
- 15/02/2008
- Grant date:
- 09/04/2014
- EP Publication Date:
- 09/04/2014
- PCT Publication Date:
- 04/09/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/12/2009
- EP B1 Publication Date:
- 09/04/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/02/2015
- Expiration date:
- 15/02/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/02/2008
- Name:
- RB Pharmaceuticals Limited
- Address:
- 103-105 Bath Road Slough, Berkshire SL1 3UH, United Kingdom (GB)
Inventor
1
- Name:
- CHAPLEO Christopher, Bourne
- Address:
- United Kingdom (GB)
2
- Name:
- HYDE Neil
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0703966
- Priority Date:
- 01/03/2007
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 45/06;
| Filing date | Document type | Number of pages |
|---|